Abstract: Cushing syndrome (CS) is scarcely observed in males. Because of this rarity, the real prevalence of gonadal dysfunction in men with hypercortisolism is unknown. Our aim was to analyze gonadal abnormalities in 37 males with CS (median age=28.9±11years) comparatively to age matched healthy men (n=10). For the homogeneity of the study men over 50, children, patients taking medications and those with pituitary deficits were systematically excluded. For the remaining group, we took into account medical history, clinical examination, and hormonal assessment, by radio immunoassay, for testosterone (T), prolactin (PRL), follicle stimulating hormone (FSH), and luteinizing stimulating hormone (LH).
INTRODUCTION
Cushing syndrome (CS) is a very rare disease even in Endocrine departments. Both adrenocorticotropin hormone (ACTH) dependent and ACTH independent CS are scarcely observed in males, but the disease is generally more severe than in females. CS complications are well known in both sexes. Cardiovascular and metabolic diseases, bone loss, hypercoagulability, immunosuppression, infections, and psychiatric problems are the most frequent and the most dangerous complications as they have a great impact on vital and functional prognoses [1] .
Gonadal dysfunction is very frequent and well described in women [2] . In male population, due to the rarity and severity of the syndrome, gonadal function is scarcely analyzed.
Experimental studies, have demonstrated that glucocorticoids excess due to a strong stress induces gonadal inhibition [3] . It was proved that reproduction, sexual behavior and testosterone levels decreased significantly in male rats with hypercortisolism. In human, it is also well established that rapid and *Address correspondence to this author at the Department of Endocrine and Metabolic Diseases, Bab El Oued Hospital, 5 Boulevard Said Touati, Algiers, Algeria; Tel/Fax: +213 21 96 00 40; Cellular Tel: +213 79 28 98 16; E-mail: chentli.f@gmail.com prolonged corticoids intake decreases sexuality and testosterone concentrations [4] . In patients with hypercortisolism, consequences on male gonadal function are reported in very small series and anecdotic cases which explain conflicting results. Our aim was to analyze sexual and gonadal function in 37 adult men suffering from hypercortisolism. In the second time, based on our results and literature review, we will discuss the possible mechanisms of gonadal inhibition due to glucocorticoids excess.
MATERIAL AND METHODS
Our group was composed of 37 men with hypercortisolism. CS diagnosis was based on high or normal morning plasma cortisol not suppressed by 2 mg dexamethasone test during 3 days, high midnight plasma cortisol ± high free urinary cortisol. These men were hospitalized between January1980 and October 2013.
In this work, for the homogeneity of our study and the role of age on gonadal function, children and adolescent (<18), and people over 50 were voluntary excluded. Files with missing information about gonadal function, patients having Cushing's disease with pituitary macro-adenomas inducing pituitary insufficiency and subjects having chronic diseases or taking medicine which acts on the hypothalamicpituitary-gonadal axis were excluded too.
Men suffering from CS were compared to 10 healthy men with normal adrenocortical, prolactin and thyroid functions, aged between 18 and 50 years old.
Median age of men with hypercortisolism was equal to 28.9 ± 11years (range: 18 -50 years). Their median plasma cortisol was equal to 391.5±489.7ng/ml (normal values= 50-250ng/ml) and was not suppressed by Dexamethasone test (2mg/day/during 3 days) in all cases.
Hypercortisolism etiologies were as follows: ACTH dependant CS was observed in 28 cases (Cushing's disease: n = 21, paraneoplastic CS: n = 7) and ACTH independent CS in 9 cases (malignant adrenal tumors: n = 6, adrenal cortical adenomas: n=2 and adrenal micro nodular dysplasia: n = 1). All had normal thyroid function before their exploration.
On the methodological point, it was a retrospective study which took into account: patients' complaints and clinical examination to seek gynecomastia and galactorrhea. Testicular volume, body hair repartition and growth, and hormonal assessment were analyzed too.
Hormonal data were based on testosterone (T), prolactin (PRL), follicle stimulating hormone (FSH), and luteinizing stimulating hormone (LH). These hormones were analyzed by radioimmunoassays. Normal ranges were: 3-9ng/ml for T, 5-20ng/ml for PRL, 1-9mUI/ml for FSH, and 1-12mUI/ml for LH. The intra-and inter assay coefficients of variation were below 8%.
Statistical Analysis
The results have been expressed as medians and ranges. We used the Student's t-test to compare our patients to age matched control group. Correlations have been expressed as Spearman's correlation coefficients (r). The difference was considered as significant if p<0.05.
RESULTS
In this group composed of adult males with cortisol excess, 8 patients (= 21%) were sent to our department for gonadal abnormalities and/or gynecomastia. After questioning them, decreased libido and erectile dysfunction were the most important complaints as they were noted in 65.7%. Except for 3 patients, body hair growth and testicular volume were described as normal. An evident clinical gynecomastia without galactorrhea was observed in 18.9%.
Concerning Hormonal Results
Median total T was equal to 2.79 ± 1.62ng/ml versus 6.69 ± 3.87ng/ml for the control group (p<0.0005). Low T (<3ng) was observed in 65.7%. Median PRL was equal to 9.8±4.2ng/ml versus 4.95 ± 2.62ng/ml for the control (p<0.01). PRL rates were all 17ng/ml. Median value for FSH was equal to 3.87 ± 1.9mu/ml versus 3.75 ± 2.25mU/ml for healthy men, but the difference was not significant (p<0.30 ). Median LH concentration=2.7 ± 2.2mU/ml versus 3.6 ± 0.8mU/ml for control; the difference was not significant too (p<0.30).
Concerning individual values, men with hypercortisolism have normal or normal/low rates of FSH and LH. Stimulation by LHRH test (done in 3 cases) was positive in 2 cases for both FSH and LH; LH response was in the upper ranges in one case. These results plead for a normal gonadotroph hypogonadism due to functional disorder of the hypothalamic pituitary axis or to a double inhibition at testicular and central levels as in hypo-or hyper metabolic diseases where vital functions are preserved and others functions (as the gonadal one) are inhibited or have a minimal function.
Concerning correlations, we didn't observe any correlation between cortisol and T (r=0.14 p<0.20), cortisol and PRL (r= -0.30 p<0.10), and cortisol and LH (r= -0.06, p<0.30). But, there was a positive and significant correlation between cortisol and FSH (r=0.57, p<0.005).
DISCUSSION
ACTH dependant CS due to Cushing's Disease and paraneoplastic causes, and independent CS due to adrenal causes (benign or malignant) are very rare diseases in males as they are 3-8 times less frequent than in women [5] [6] [7] . Because of this rarity there are very few studies about gonadal abnormalities in male suffering from hypercortisolism. But, as in severe or critical illnesses where there is an important proteins' catabolism [8] [9] [10] , it seems obvious that cortisol excess is responsible for male hypogonadism. But other mechanisms are also possible.
In this study which analyses 37 males with clinical and biological CS, 21% of our population consulted for gonadal abnormalities and/or gynecomastia. When they were questioned, 65.7% complained about decreased libido and loss of erectile function. Sexual dysfunction was also observed in 58% (7/12) by Luton et al. [11] .
In people taking corticoids, erectile dysfunction was also reported by some authors. The frequency of sexual abnormalities varies from 55 to 100% according to different series [4, 12, 13] .
In our subjects body hair growth and repartition, and testicular volume (based on clinical examination), were described as normal as reported by other researchers.
It would be interesting to analyze testes volume on echosonography which is more objective, but to our knowledge there is not any published study about this subject.
Gynecomastia without galactorrhea was observed in 18.9%. This abnormality, certainly underestimated as echosonography and mammography were not systematically done, is probably due to an increase transformation of testosterone to estradiol as demonstrated by MC Kenna et al. in two cases [13] .
Compared to the control group, total testosterone rates were significantly lower in subjects with hypercortisolism. The same results were observed by many authors [4, 11, 12, [14] [15] [16] [17] . Low testosterone was demonstrated in 65.7% of our population versus 75% to 100% in other series [11, 13, 14] .
Contreras reported a decrease in free testosterone in patients suffering from hypercortisolism compared to normal subjects [12] . For this author the decrease in free testosterone was correlated to plasma cortisol concentration and to the hypercortisolism duration as confirmed by Meij [12, 18] .
In our study we have not found any correlation between cortisol, LH and PRL. But there was a positive and significant correlation with FSH.
The inhibition in gonadal function is usually reversible, as testosterone rates return to normal values after cortisol normalization [11] or after stopping corticoids administration [4] .
The mechanism of testosterone inhibition is still debated. According to Luton et al., low testosterone is due to an inhibition at the hypothalamic and pituitary levels. This inhibition is responsible for a decrease in FSH and LH production and release [11] .
In our study, as in Meij's publication concerning dogs [18] , basal FSH and LH were normal or normal low, but after LHRH administration, LH release was normal or excessive. Other authors have reported the same profile suggesting a hypothalamic deregulation [4, 12, 13] . That one is probably secondary to cortisol excess and/or to a perturbation in opioid peptides secretion. For this last hypothesis pleads the increase in plasma testosterone under Cyproheptadine treatment observed by Kriger et al. in one case suffering from CS [9] .
Many other authors have suggested a lack in LHRH production and/or pulsatility. But, except in primates [20] no one has proved this theory in humans. Cortisol excess seems to inhibit LHRH neurons as those are known to express corticoids receptors [21] . Chronic hypercortisolism may also block testes sensitivity to FSH and LH and/or to LHRH [22] .
Some researchers think there is also a decrease in the sensitivity of the gonadal regulator to testosterone levels which explains the discrepancy between low testosterone and normal/low FSH and LH.
The role of prolactin is also discussed to explain the normal gonadotroph hypogonadism, because as in our work, Meij et al. demonstrated a relative basal hyper prolactinemia [18] . These authors have also proved an excessive response of PRL to thyreotropin-releasing hormone (TRH), but other researchers ruled out this hypothesis, because as in our study individual rates were absolutely normal.
Low free testosterone may be explained by an increase in testosterone binding protein (SBP) as demonstrated by Bezvekhaia et al. [15] , but this result was not confirmed by Contreras et al. [12] . Luton et al. suggested an increase in gonadal androgens degradation due to proteins' hyper catabolism [11] as degradation in proteins is at its maximum in males suffering from hypercortisolism.
In some studies the role of ACTH is suggested to explain low testosterone, but decreased testosterone was observed in ACTH and in non ACTH dependant CS. On the other hand, Luton et al. did not find any correlation between low testosterone and ACTH concentrations [11] and Shaison et al. demonstrated that low testosterone after ACTH injection is due to cortisol excess because testosterone was not modified by Metopirone test, but decreased after dexamethasone test [23] . For these authors glucocorticoids act at two levels: they decrease testosterone biosynthesis and increase testosterone catabolism. In humans it is well demonstrated that dexamethasone inhibits testosterone release before and after human chorionic gonadotropins (HCG) test [11, 12, 18, 23] . In CS low testosterone is exaggerated after dexamethasone test [14] .
For other researchers, glucocorticoids excess acts on the testes too by inhibiting and or/reducing FSH and LH receptors which may explain low testosterone response after HCG administration demonstrated by Kuhn et al. [4] . Glucocorticoids' receptors in the testis are well proved in animals. These receptors modulate Leydig's cells response to LH, and the enzymes which are necessary to testosterone biosynthesis. As suggested by Ge et al., intra testicular and plasma glucocorticoids excess inhibit LH action and enzymes coding for testosterone production [24] .
According to Mc Kenna et al., glucocorticoids are responsible for a double inhibition in testosterone production: in the testis and in the hypothalamic pituitary axis [13] , but the real mechanism is still debated.
In summary one can understand that according to some human analyses and especially experimental studies, low testosterone observed in men with CS may be due to at least 2 mechanisms: inhibition of testosterone production at hypothalamic and testicles levels, and an increase in androgens degradation secondary to protein hyper catabolism that characterizes hypercortisolism condition.
CONCLUSION
In our study concerning 37 men with Cushing syndrome (28 ACTH dependent, 9ACTH independent), 65.7% complained about a decrease in libido and erectile function. Low testosterone was proved in 65% and in 35% testosterone was normal. FSH and LH were normal-low, but the response to LHRH (n=3) was normal or excessive for LH. The normal gonadotroph hypogonadism is suggestive of a functional inhibition of FSH and LH release or pulsatility. But, a testicular action of glucocorticoids' excess, and/or testosterone degradation cannot be totally excluded.
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